Dexamethasone-induced hypertrophy in rat neonatal cardiac myocytes involves an elevated L-type Ca(2+)current

Area of Science:

• Cardiology
• Molecular Biology
• Cell Biology

Background:

• The mechanisms underlying dexamethasone-induced cardiac hypertrophy in infants remain unclear.
• Cardiac hypertrophy involves cellular enlargement and is a significant concern in pediatric medicine.

Purpose of the Study:

• To investigate the role of L-type calcium currents in dexamethasone-induced cardiac myocyte hypertrophy.
• To elucidate the molecular mechanisms connecting dexamethasone treatment to cardiac cell growth.

Main Methods:

• Primary neonatal rat cardiac myocytes were treated with dexamethasone.
• Cell size was measured using cytoplasmic membrane capacitance.
• L-type calcium currents were assessed using electrophysiology.
• mRNA expression of L-type calcium channel subunits was quantified.
• Intracellular calcium transients were measured using fura-2/epifluorescence.
• The effect of nifedipine, an L-type calcium channel antagonist, was evaluated.

Main Results:

• Dexamethasone treatment increased cardiac myocyte size and protein content.
• A significant increase in L-type calcium current density was observed, linked to elevated alpha(1)C subunit mRNA.
• Dexamethasone enhanced peak intracellular calcium transient amplitude.
• Nifedipine administration blocked the hypertrophic effects of dexamethasone.

Conclusions:

• Elevated L-type calcium currents are integral to dexamethasone-induced cardiac myocyte hypertrophy in neonatal rats.
• Dexamethasone promotes cardiac hypertrophy partly through modulation of L-type calcium channels and intracellular calcium handling.